Skip to main content

Table 1 Perioperative characteristics of patients who underwent RARC between 2005 and 2016 (OC vs. LAD)

From: Quality of surgical care can impact survival in patients with bladder cancer after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium

VariableOCDLADp value
N (%)703 (52)640 (48)
Preoperative
 Age, mean (SD), years67 (10)68 (10)0.04
 Sex, males, n (%)528 (75)461 (72)0.24
 BMI, kg/m2, mean (SD)28 (5)27 (5)0.01
 ASA score, median (IQR)2 (2–3)3 (2–3)0.06
 Prior surgery, n (%)221 (31)209 (33)0.63
 NAC, n (%)139 (20)126 (20)0.97
Operative
 Ileal conduit,n(%)503 (72)529 (83)< 0.001
 Intracorporeal diversion, n (%)435 (76)347 (72)0.12
 Operative time, median (IQR), min371 (310–450)369 (310–442)0.80
 EBL, mean (SD), ml376 (339)444 (513)0.05
Perioperative
 Hospital stay, median (IQR), days9 (7–13)9 (7–13)0.42
 ICU stay, median (IQR), days1 (0–1)1 (0–1)0.73
 Adjuvant treatment,n(%)26 (4)154 (24)< 0.001
 30-d complications, n (%)224 (32)205 (32)0.95
 90-d complications, n (%)261 (37)249 (39)0.50
 30-d high-grade complications, n (%)63 (9)72 (11)0.16
 90-d high-grade complications, n (%)74 (11)88 (14)0.07
 30-d readmission, n (%)48 (7)50 (8)0.49
 90-d readmission, n (%)85 (12)91 (14)0.25
 30-d mortality, n (%)4 (0.6)7 (1)0.29
 90-d mortality,n(%)12 (1.9)33 (6)< 0.001
Pathologic
 LNY, mean (SD)18 (11)18 (11)0.86
 Positive LN, n (%)0 (0)301 (47)NA
 Pathologic T stage > 20 (0)544 (86)NA
 PSM,n(%)16 (2)89 (14)< 0.001
 Any recurrence,n(%)73 (10)252 (39)< 0.001
 Local recurrence,n(%)31 (4)123 (19)< 0.001
 Distant recurrence (n)56 (8)198 (31)< 0.001
 Median time to any recurrence (months)12 (6-21)6 (3-11)< 0.001
 Non-TCC histology, n (%)163 (30)171 (30)0.76
QCS domains
 Preoperative139 (20)126 (20)0.97
 Operative359 (51)318 (50)0.61
 Postoperative603 (86)529 (83)0.12
Pathologic266 (38)209 (33)0.05
  1. Bold indicates statistically significant difference